Trial Profile
A pilot study to evaluate the effect of Forsteo (Teriparatide, 1-34 rh-PTH) in Anorexia Nervosa patients with low mineral density and increased bone fragility (FAN-Trial)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Biomarker; Therapeutic Use
- Acronyms FAN-Trial
- 07 Mar 2013 New trial record